Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.
about
AIDS-defining illnesses among patients with HIV in Singapore, 1985 to 2001: results from the Singapore HIV Observational Cohort Study (SHOCS)HIV-associated lung infections and complications in the era of combination antiretroviral therapy.Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational DatabaseIncidence, risk factors and mortality of tuberculosis in Danish HIV patients 1995-2007Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.Tuberculosis risk factors and mortality for HIV-infected persons receiving antiretroviral therapy in South Africa.Tuberculosis mortality, drug resistance, and infectiousness in patients with and without HIV infection in Peru.HIV-Associated Tuberculosis.Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.Dissection of regenerating T-Cell responses against tuberculosis in HIV-infected adults sensitized by Mycobacterium tuberculosis.Antiretroviral therapy for tuberculosis control in nine African countries.Tuberculosis, lung infections, and interstitial lung disease in AJRCCM 2000.Miliary tuberculosis coinfection with human immunodeficiency virus.HIV-Care Outcome in Saudi Arabia; a Longitudinal Cohort.Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies.Management of patients with HIV in the intensive care unitImmune reconstitution and "unmasking" of tuberculosis during antiretroviral therapyT cells home to the thymus and control infectionLife and death in the granuloma: immunopathology of tuberculosis.Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South AfricaHIV-Related Lung DisordersAspartic peptidases of human pathogenic trypanosomatids: perspectives and trends for chemotherapy.Impact of antiretroviral therapy on lung immunology and inflammation.Diagnosis and Management of a Pancreaticopleural Fistula in a Patient with AIDS and a Large Pleural Effusion.Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.Antiretroviral agents restore Mycobacterium-specific T-cell immune responses and facilitate controlling a fatal tuberculosis-like disease in Macaques coinfected with simian immunodeficiency virus and Mycobacterium bovis BCGRefining Current Scientific Priorities and Identifying New Scientific Gaps in HIV-Related Heart, Lung, Blood, and Sleep Research.The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.Assessment of mycobacteremia detection as a complementary method for the diagnosis of tuberculosis in HIV-infected patients.Disseminated Mycobacterium avium complex disease among patients infected with human immunodeficiency virus, 1985-2000.Risk of tuberculosis among HAART receiving HIV patients attending an ART centre of West Bengal, India: a prospective cohort study.Tuberculosis incidence and risk factors among patients living with HIV/AIDS in public health service institutions in Brasilia, Federal District.Diagnostic discrepancy between bronchoalveolar lavage and transbronchial biopsy from bronchoscopies of HIV patients with pneumonia: toward an integral diagnosis.HIV-related morbidity and mortality in patients starting protease inhibitors in very advanced HIV disease (CD4 count of < 50 cells/uL): an analysis of 338 clinical events from a randomized clinical trial*
P2860
Q24802044-D5486EA5-AC74-4532-84D8-E74AC4C015F7Q27693307-E8984A67-1032-4BA9-9542-259A656D175FQ33433188-832D0CDD-2B61-46E8-8767-38461946DD6DQ33909179-146EE933-70AF-478A-BAB2-B755132EB946Q33920318-60FD3CEF-5F46-4581-B935-DB4F01A847C1Q33997536-D347F856-E014-4C7D-BE42-F347F7BE9BF6Q34030008-E37C51D3-38D6-4041-B72D-3B42AE6ABFDFQ34143510-4FA49DC3-47C3-49E2-8147-DFF27DD7175CQ34213437-88E4C7E3-906E-41F3-A26D-682B65B0790EQ34251506-D4572458-93DF-4188-9003-822CC1D8ED06Q34320245-83E3D9B0-0AC6-4B1C-BD93-6B4F0C20AF46Q34457540-D1962B9E-5D6E-456B-8A6A-8416740164DDQ34522835-74B5A4F9-0CEF-4F29-BC75-0B46AF700974Q35149265-7665BF2B-B048-47E0-8834-78B3D89D28E4Q35870509-41806650-E42C-432D-9141-86AC880A72F4Q36403151-D26D33F7-6674-4EFA-A600-ACD001361923Q36514050-98CF105B-2D1C-40D7-BCDD-749E40625B49Q36586192-70AFE567-75F0-490D-BAC2-7127816D0642Q36703585-571CCFD7-60CC-4C31-80CF-17F339FCE43BQ37240761-4EC3B73C-B496-4DE8-AD4C-A2607C8B8B79Q37245925-E83332B4-5682-44EB-87EB-17793E14A752Q37334816-09276DF6-9FC6-4E7E-92E8-E3D17B437372Q38108963-98FE33A6-A71A-471A-AD6A-4239809D2020Q38961392-6611C40C-64AE-4962-99A4-F452A7349271Q39448183-2B9B1CAB-2EAF-457E-A0CC-0D6BA30198F4Q39607060-13A65DB9-AE64-4C58-BC9D-0298B96E5CD9Q40191380-B0AA6B6F-B502-4257-A5AD-F0768E60B122Q42278556-1A65A55B-CC09-493E-92C4-632188FF4C4EQ42928226-68963EDD-BE65-4726-9D75-8B33D33BA04CQ43787824-90AB351E-665D-42B6-BBD8-2F9641FE0D56Q44025752-849CB686-EA7B-47CA-A8D0-7578BC917B32Q44095305-AAE6F70E-196B-4293-B4EA-94684F94B116Q55661228-D377DCE2-FAE7-4BDE-AAF1-90EA63C24ACEQ58960862-DD4C169E-EB9A-4122-9B50-CE3B42B6CA80
P2860
Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Infections with Mycobacterium ...... rapy. EuroSIDA Study Group JD.
@en
type
label
Infections with Mycobacterium ...... rapy. EuroSIDA Study Group JD.
@en
prefLabel
Infections with Mycobacterium ...... rapy. EuroSIDA Study Group JD.
@en
P2093
P2860
P1476
Infections with Mycobacterium ...... rapy. EuroSIDA Study Group JD.
@en
P2093
Brettle RP
Pedersen C
Phillips AN
P2860
P304
P356
10.1164/AJRCCM.162.3.9908018
P407
P433
P577
2000-09-01T00:00:00Z